184 related articles for article (PubMed ID: 31662808)
1. Effect of Tiotropium Bromide on Airway Inflammation and Programmed Cell Death 5 in a Mouse Model of Ovalbumin-Induced Allergic Asthma.
Wang J; Diao X; Zhu H; He B
Can Respir J; 2019; 2019():6462171. PubMed ID: 31662808
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of programmed cell death 5 in a mouse model of ovalbumin-induced allergic asthma.
Diao X; Wang J; Zhu H; He B
BMC Pulm Med; 2016 Nov; 16(1):149. PubMed ID: 27846830
[TBL] [Abstract][Full Text] [Related]
3. Effect of tiotropium bromide on airway remodeling in a chronic asthma model.
Kang JY; Rhee CK; Kim JS; Park CK; Kim SJ; Lee SH; Yoon HK; Kwon SS; Kim YK; Lee SY
Ann Allergy Asthma Immunol; 2012 Jul; 109(1):29-35. PubMed ID: 22727154
[TBL] [Abstract][Full Text] [Related]
4. Effect of tiotropium bromide on airway inflammation and remodelling in a mouse model of asthma.
Ohta S; Oda N; Yokoe T; Tanaka A; Yamamoto Y; Watanabe Y; Minoguchi K; Ohnishi T; Hirose T; Nagase H; Ohta K; Adachi M
Clin Exp Allergy; 2010 Aug; 40(8):1266-75. PubMed ID: 20337647
[TBL] [Abstract][Full Text] [Related]
5. A Muscarinic Antagonist Reduces Airway Inflammation and Bronchoconstriction Induced by Ambient Particulate Matter in a Mouse Model of Asthma.
Kurai J; Watanabe M; Sano H; Iwata K; Hantan D; Shimizu E
Int J Environ Res Public Health; 2018 Jun; 15(6):. PubMed ID: 29882826
[TBL] [Abstract][Full Text] [Related]
6. The effect of tiotropium in combination with olodaterol on house dust mite-induced allergic airway disease.
John-Schuster G; de Kleijn S; van Wijck Y; Kremer V; Smits HH; Pieper MP; Hiemstra PS; Taube C
Pulm Pharmacol Ther; 2017 Aug; 45():210-217. PubMed ID: 28687462
[TBL] [Abstract][Full Text] [Related]
7. Effects of tiotropium bromide on airway hyperresponsiveness and inflammation in mice exposed to organic dust.
Gregory JA; Kemi C; Ji J; Karén J; Delin I; Gerde P; Pieper MP; Adner M; Larsson K
Pulm Pharmacol Ther; 2018 Feb; 48():203-210. PubMed ID: 29247703
[TBL] [Abstract][Full Text] [Related]
8. Protective effects of tiotropium bromide in the progression of airway smooth muscle remodeling.
Gosens R; Bos IS; Zaagsma J; Meurs H
Am J Respir Crit Care Med; 2005 May; 171(10):1096-102. PubMed ID: 15695490
[TBL] [Abstract][Full Text] [Related]
9. Tiotropium bromide inhibits relapsing allergic asthma in BALB/c mice.
Bosnjak B; Tilp C; Tomsic C; Dekan G; Pieper MP; Erb KJ; Epstein MM
Pulm Pharmacol Ther; 2014 Feb; 27(1):44-51. PubMed ID: 24090641
[TBL] [Abstract][Full Text] [Related]
10. Combination therapy of tiotropium and ciclesonide attenuates airway inflammation and remodeling in a guinea pig model of chronic asthma.
Kistemaker LE; Bos IS; Menzen MH; Maarsingh H; Meurs H; Gosens R
Respir Res; 2016 Feb; 17():13. PubMed ID: 26846267
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and Safety of Tiotropium in Children and Adolescents.
Hamelmann E; Szefler SJ
Drugs; 2018 Mar; 78(3):327-338. PubMed ID: 29368127
[TBL] [Abstract][Full Text] [Related]
12. Second M
Kistemaker LEM; Elzinga CRS; Tautermann CS; Pieper MP; Seeliger D; Alikhil S; Schmidt M; Meurs H; Gosens R
Br J Pharmacol; 2019 Aug; 176(16):2864-2876. PubMed ID: 31077341
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic Effects of a Long-Acting Cholinergic Receptor Blocker, Tiotropium Bromide, on Asthma.
Zhang L; Huang G; Jin L; Han S
Med Sci Monit; 2018 Feb; 24():944-950. PubMed ID: 29446377
[TBL] [Abstract][Full Text] [Related]
14. Expression of Muscarinic Receptors and the Effect of Tiotropium Bromide in Aged Mouse Model of Chronic Asthma.
Kang JY; Kim IK; Hur J; Kim SC; Lee SY; Kwon SS; Kim YK
Tuberc Respir Dis (Seoul); 2019 Jan; 82(1):71-80. PubMed ID: 30574690
[TBL] [Abstract][Full Text] [Related]
15. Comparison between montelukast and tiotropium as add-on therapy to inhaled corticosteroids plus a long-acting β
Hoshino M; Akitsu K; Ohtawa J
J Asthma; 2019 Sep; 56(9):995-1003. PubMed ID: 30212239
[No Abstract] [Full Text] [Related]
16. Involvement of Muscarinic M3 Receptor in the Development of M2 Macrophages in Allergic Inflammation.
Jinno M; Ohta S; Mikuni H; Uno T; Uchida Y; Manabe R; Miyata Y; Homma T; Watanabe Y; Kusumoto S; Suzuki S; Tanaka A; Sagara H
Int Arch Allergy Immunol; 2024 Apr; ():1-10. PubMed ID: 38565078
[TBL] [Abstract][Full Text] [Related]
17. Anticholinergics for asthma: a long history.
Rodrigo GJ
Curr Opin Allergy Clin Immunol; 2018 Feb; 18(1):38-43. PubMed ID: 29040210
[TBL] [Abstract][Full Text] [Related]
18. Why choose tiotropium for my patient? A comprehensive review of actions and outcomes versus other bronchodilators.
Halpin DM; Kaplan AG; Russell RK
Respir Med; 2017 Jul; 128():28-41. PubMed ID: 28610667
[TBL] [Abstract][Full Text] [Related]
19. Tiotropium for the treatment of asthma in adolescents.
Hamelmann E; Vogelberg C; Szefler SJ
Expert Opin Pharmacother; 2017 Feb; 18(3):305-312. PubMed ID: 28110558
[TBL] [Abstract][Full Text] [Related]
20. A phase III randomized controlled trial of tiotropium add-on therapy in children with severe symptomatic asthma.
Szefler SJ; Murphy K; Harper T; Boner A; Laki I; Engel M; El Azzi G; Moroni-Zentgraf P; Finnigan H; Hamelmann E
J Allergy Clin Immunol; 2017 Nov; 140(5):1277-1287. PubMed ID: 28189771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
